ExLibris header image
SFX Logo
Title: Appropriate evidence for adaptive marketing authorization
Source:

Nature Reviews Drug Discovery [1474-1776] de Jong, Jean yr:2013


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Doaee, Sh. "Development and implementation of health technology assessment: a policy study." Iranian Journal of Public Health 42.Supple1 (2013): 50-4. Link to Full Text for this item Link to SFX for this item
2. Stargardt, Frans m. "Reimbursement of pharmaceuticals: reference pricing versus health technology assessment." The European journal of health economics 12.3 (2010): 263-71. Link to Full Text for this item Link to SFX for this item
3. Lee D;, D. "Health economics in technology development: is it worth it?" The Journal of nuclear medicine 49.6 (2008): 48-50. Link to SFX for this item
4. Banta, D. "The development of health technology assessment." Health policy 63.2 (2003): 121-32. Link to SFX for this item
5. Longo, Christopher J. "Global Pharmaceutical Pricing Strategies: Profit Implications of Price Discounting." International journal of economics and business research 2.6 (2010): 447-60. Link to SFX for this item
6. Fulop, N. "From health technology assessment to research on the organisation and delivery of health services: addressing the balance." Health policy 63.2 (2003): 155-165. Link to SFX for this item
7. Drummond, M. "Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report." Value in health 12.4 (2009): 409-418. Link to Full Text for this item Link to SFX for this item
8. Tett, Nadia E. "Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing." Clinical therapeutics 31.4 (2009): 849-61. Link to SFX for this item
9. Iliffe, S. "User involvement in the development of a health promotion technology for older people: findings from the SWISH project." Health & social care in the community 18.2 (2009): 147-59. Link to Full Text for this item Link to SFX for this item
10. Busse, R. "Regulation of pharmaceutical markets in Germany : improving efficiency and controlling expenditures?" The international journal of health planning and management 20.4 (2005): 329-349. Link to Full Text for this item Link to SFX for this item
11. Oliver, A. "Health technology assessment and its influence on health-care priority setting." International journal of technology assessment in health care 20.1 (2004): 1-10. Link to SFX for this item
12. Biller-Andorno, N. "Evidence-based medicine as an instrument for rational health policy." Health care analysis 10.3 (2002): 261-75. Link to Full Text for this item Link to SFX for this item
13. Drummond, M F F. "Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party." BMJ 313.7052 (1996): 275-83. Link to SFX for this item
14. Moreno-Torres, I. "Impact of pharmaceutical prior authorisation policies : a systematic review of the literature." PharmacoEconomics 25.8 (2007): 637-48. Link to SFX for this item
15. Chang, PL L. "The innovation systems of Taiwan and China: a comparative analysis." Technovation 24.7 (2004): 529-539. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.